✦ LIBER ✦

Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia

✍ Scribed by Claes Karlsson; Jeanette Lundin; Eva Kimby; Ben Kennedy; Paul Moreton; Peter Hillmen; Anders Österborg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Italian retrospective study on the ro

✍ Agostino Cortelezzi; Giuseppe Gritti; Luca Laurenti; Antonio Cuneo; Stefania Cio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Phase II study of the histone deacetylas

✍ Kristie A. Blum; Anjani Advani; Louis Fernandez; Richard Van Der Jagt; Joseph Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

A phase II, open-label, sequential-cohor

✍ Yukari Shirasugi; Kiyoshi Ando; Satoshi Hashino; Toshiro Nagasawa; Yoshiyuki Kur 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 253 KB

Phase I trial of low dose decitabine tar

✍ Kristie A. Blum; Zhongfa Liu; David M. Lucas; Ping Chen; Zhiliang Xie; Robert Ba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Phase-I/II study to evaluate dose limiti

✍ T. Lissitchkov; G. Arnaudov; D. Peytchev; Kh. Merkle 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 183 KB

Consolidation with alemtuzumab improves

✍ Carmen D. Schweighofer; Matthias Ritgen; Barbara F. Eichhorst; Raymonde Busch; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB